Published • loading... • Updated
Executive Change: Synthekine Inc. Appoints Susan M. Molineaux Ph.D. as Chief Executive Officer
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Executive Change: Synthekine Inc. Appoints Susan M. Molineaux Ph.D. as Chief Executive Officer
Menlo Park, CA – Synthekine has announced the appointment of Susan Molineaux as Chief Executive Officer. About Synthekine: Synthekine is a biotechnology company that focuses on discovering, developing, and commercializing the next generation of selective cytokine therapeutics to improve treatment for patients with cancer and autoimmune or inflammatory diseases. From its website, the company describes itself as applying distinct protein engineeri…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
